Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 196
- Proje 0
- Kitap 0
- Bildiri 94
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
58
Q2
34
Q3
39
Q4
32
WoS (JCR)
Q1
17
Q2
38
Q3
49
Q4
72
TR Index
43
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
39
Ort. yüzdelik
61.9%
Üst %1 payı
0.0%
Üst %10 payı
25.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 Impact of the COVID-19 Pandemic on Diabetic Foot Patients: A Shift in the Infectious Agent Profile Toward Nonfermentative Gram-Negative Bacilli YÖKSİS SJR Q3 JCR Q4 OpenAlex 57.8%
- 2024 Impact of the COVID-19 Pandemic on Diabetic Foot Patients: A Shift in the Infectious Agent Profile Toward Nonfermentative Gram-Negative Bacilli YÖKSİS SJR Q3 JCR Q4 OpenAlex 57.8%
- 2023 Özel Hasta Gruplarında Kronik Hepatit B Yönetimi: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu Uzlaşı Raporu-2023 Güncellemesi YÖKSİS TR Index SJR Q4 JCR Q3 OpenAlex 71.7%
- 2023 The Effects of Antimicrobial Resistance and the Compatibility of Initial Antibiotic Treatment on Clinical Outcomes in Patients With Diabetic Foot Infection YÖKSİS SJR Q2 JCR Q3 OpenAlex 89.4%
- 2023 Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.0%
- 2022 Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.8%
- 2022 Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates YÖKSİS SJR Q2 JCR Q3 OpenAlex 33.2%
- 2022 High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolates YÖKSİS SJR Q2 JCR Q3 OpenAlex 47.8%
- 2022 Characteristics and outcomes of carbapenemase harbouring carbapenem‑resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA‑48 endemic setting YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.8%
- 2021 Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective? YÖKSİS SJR Q3 JCR Q4 OpenAlex 50.1%
- 2021 The Effects of Antimicrobial Resistance and the Compatibility of Initial Antibiotic Treatment on Clinical Outcomes in Patients With Diabetic Foot Infection YÖKSİS SJR Q3 JCR Q3 OpenAlex 89.4%
- 2021 Assessment of pulmonary arterial hemodynamic and vascular changes by pulmonary pulse transit time in patients with human immunodeficiency virus infection YÖKSİS SJR Q4 JCR Q4 OpenAlex 64.8%
- 2021 The Etiology and Clinical Follow-up of Patients with Acute Viral Hepatitis in an Adult Population: A Prospective Multicenter Study YÖKSİS SJR Q4 JCR Q4 OpenAlex 12.5%
- 2021 The Etiology and Clinical Follow-up of Patients with Acute Viral Hepatitis in an Adult Population: A Prospective Multicenter Study YÖKSİS SJR Q4 JCR Q4 OpenAlex 12.5%
- 2021 Diagnostic and Prognostic Values of Serum C-reactive Protein, Procalcitonin, Soluble Urokinase Plasminogen Activator Receptor, and Neopterin Levels in Hospitalized Patients in the Intensive Care Unit with Ventilator-associated Pneumonia YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 9.8%
- 2021 COVID-19 Sürecinde Tıp Eğitimi ve Atılım Üniversitesi Tıp Fakültesi Deneyimi YÖKSİS TR Index OpenAlex 61.8%
- 2020 Evaluation of Infectious Diseases in Pregnant Women YÖKSİS SJR Q4 JCR Q3 OpenAlex 11.6%
- 2020 Evaluation of Infectious Diseases in Pregnant Women YÖKSİS SJR Q4 JCR Q3 OpenAlex 11.6%
- 2020 Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.8%
- 2020 Real world data from Turkey: Is sofosbuvir/ledipasvir with or without ribavirin treatment for chronic Hepatitis C really effective? YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 50.1%